Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1093/eurheartj/ehaa506

Type

Journal article

Journal

Eur Heart J

Publication Date

14/06/2020

Volume

41

Pages

2140 - 2144

Keywords

Anti-Bacterial Agents, Antibodies, Monoclonal, Humanized, Anticoagulants, Antimalarials, Antiviral Agents, Azithromycin, Betacoronavirus, Biomedical Research, Clinical Laboratory Techniques, Coronavirus Infections, Data Accuracy, Device Approval, Diagnostic Test Approval, Drug Approval, Drug and Narcotic Control, European Union, Glucocorticoids, Heparin, Humans, Immunization, Passive, Medical Device Legislation, Pandemics, Personal Protective Equipment, Pneumonia, Viral, Ventilators, Mechanical